Ghrelin does not directly stimulate secretion of glucagon-like peptide-1.
The gastrointestinal hormone ghrelin stimulates growth hormone secretion and appetite, but recent studies indicate that ghrelin also stimulates the secretion of the appetite-inhibiting and insulinotropic hormone glucagon-like peptide-1 (GLP-1). To investigate the putative effect of ghrelin on GLP-1 secretion in vivo and in vitro. A randomized placebo-controlled crossover studies was performed in eight hypopituitary subjects. Ghrelin or saline was infused intravenously (1 pmol/min x kg) after collection of baseline sample (0 min), and blood was subsequently collected at time 30, 60, 90, and 120 min.Mouse small intestine was perfused (n= 6) and GLP-1 output from perfused mouse small intestine was investigated in response to vascular ghrelin administration in the presence and absence of a simultaneous luminal glucose stimulus. Ghrelin receptor expression was quantified in human (n=11) and mouse L-cells (n=3) by RNA sequencing and RT-qPCR, respectively. Ghrelin did not affect GLP-1 secretion in humans [AUC(0-120 min): ghrelin infusion=1.37±0.05 min x nmol vs. saline infusion=1.40±0.06 min x nmol (P = 0.63)], but induced peripheral insulin resistance. Likewise, ghrelin did not stimulate GLP-1 in the perfused mouse small intestine model (mean outputs during baseline/ghrelin infusion = 19.3±1.6/25.5±2.0 fmol/min, n=6, P=0.16), whereas glucose-dependent insulinotropic peptide administration, used as a positive control, doubled GLP-1 secretion (P<0.001). Intra-luminal glucose increased GLP-1 secretion by 4-fold (P<0.001) which was not potentiated by ghrelin. Finally, gene expression of the ghrelin receptor was undetectable in mouse L-cells and marginal in human L-cells. Ghrelin does not interact directly with the L-cell and does not directly affect GLP-1 secretion.